logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
17/07/2026
The UK Maritime Trade Operations office stated that they have received a report of an incident occurring 19 nautical miles east of Hsab, Oman.
Latest
3 m ago
Alitongyi Laboratory releases Wan-Streamer v0.2 model.
4 m ago
Nokia's share price fell 4.1% in early trading, with a cumulative decline of 19.5% for the week.
4 m ago
According to an internal memo, United Airlines (UAL.O) plans to offer free rebooking services to passengers who do not wish to arrive at the newly renamed "Donald J. Trump President International Airport" in Florida. The airport was previously known as Palm Beach International Airport. According to an internal memo obtained by Live And Lets Fly, passengers who oppose using this airport as their destination can change their flights to Fort Lauderdale-Hollywood International Airport or Miami International Airport at no extra cost.
4 m ago
Announce: The planning to purchase 100% equity of Guangzhou Fengyun is in progress. Transaction work is currently underway.
4 m ago
Sinopharm: The first subject for multiple doses in Phase I/II clinical trial of VUM02 injection entered the group.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.